The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

The BioSecure Act seeks to reduce US-China biotech ties, creating potential for India to become a biomanufacturing hub.

Ltd., Thermo Fisher Scientific Inc., and Vertex Pharmaceuticals Inc. The biotech market is experiencing significant growth with trends such as genetic engineering and precision medicine leading ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

This week’s episode of The Top Line dives into the discussion, featuring Fierce Biotech’s Gabrielle Masson ... biotechs that debuted on the public market in 2024, the keys to success for ...

NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global biotech market size is estimated to grow by USD 805.6 billion from 2025-2029, according to Technavio.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...